Equity Profile

STE

STERIS plc

Health CareHealth Care Equipment$20.9B

May11Mon

Post-Earnings Recap

ReportedQ4-2026After Close4:30 PM EDT

STERIS plc Misses on EPS, Stock Down 2.7%

Metric	Actual	Expected	Surprise
EPS	$2.83	$2.85	-0.88%
Revenue	—	$1.6B	—

management commentary, guidance changes, and full analysis available with Pro.

STERIS plc Misses on EPS, Stock Down 2.7%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$2.83	$2.85	-0.88%
Revenue	—	$1.6B	—

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

STERIS plc reported earnings that fell short of expectations, particularly in EPS. The stock reacted negatively, declining by 2.7%. Investors may be concerned about the company's performance and future outlook given the earnings miss and lack of revenue data.

Company Snapshot

STERIS plc is a healthcare company that provides products and services for infection prevention and surgical procedures. With a market cap of $21 billion, it plays a crucial role in the healthcare equipment industry, particularly as demand for health-related services continues to grow.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$2.85

Revenue

Revenue figures provide insight into the company's sales performance and market demand.

$1.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+1.57%

Avg Stock Reaction

-0.34%

Last Quarter Recap

In Q3 2026, STERIS reported an EPS of $2.53, matching analyst expectations. The stock saw a modest increase of nearly 1% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect STERIS to report solid earnings, with a consensus EPS of $2.85. The market is closely watching how the company navigates ongoing challenges in the healthcare sector.

Bull Case

If STERIS exceeds EPS expectations, it could signal strong demand for its products and services, potentially boosting investor confidence.

Bear Case

Conversely, if the company misses EPS estimates, it may raise concerns about its growth prospects and market position.

Key Metrics to Watch

EPS

$2.85

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$1.6B

Revenue figures provide insight into the company's sales performance and market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will STERIS achieve an EPS of $2.85 or higher?

This figure is critical as it sets the tone for investor confidence and reflects the company's profitability.

What insights will management provide regarding revenue growth?

Understanding revenue trends can indicate how well STERIS is performing in the competitive healthcare market.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may be underestimating the impact of recent healthcare trends on STERIS's revenue growth potential.

Supporting Evidence

The company's strong historical EPS beat rate of 88% suggests it often exceeds expectations.

Options pricing indicates a significant expected move, which may reflect uncertainty not captured in consensus estimates.

Key Risk

If management provides strong guidance on revenue growth, it could challenge the current consensus outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it reflects STERIS's ability to navigate market challenges and meet investor expectations.

Bull Confirmed If

An EPS of $2.90 or above would confirm strong operational performance.

Bear Confirmed If

An EPS below $2.81 could indicate underlying issues affecting profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±5.6%

Historical Avg

±1.0%

Pricing rich

The options market is pricing in a significant move following the earnings report, suggesting heightened volatility expectations.

Options are pricing ±6.0% while STE has averaged ±1.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

24.0%

Calls (3K)P/C Ratio: 0.90Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 6 of 12 (50%)

This setup has occurred 30 times across Health Care in the last 2 years. 6 of 12 faded and 6 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 4.5%, with a raw directional average of -0.4% (modestly negative historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If STERIS beats expectations, history suggests the stock could see a modest increase, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may remain stable, but cautious commentary could lead to volatility.

Miss

A miss on EPS could lead to a decline, with history suggesting an average drop of around 1% following such outcomes.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

3 buys·0 sells

Members

House only

Est. Notional

$3,003.00–$45,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in infection prevention.
2Insights into market demand trends for healthcare equipment.
3Management's outlook on cost pressures and how they plan to address them.
4Details on any recent acquisitions or partnerships that could impact growth.
5Comments on competitive positioning within the healthcare equipment sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May8

JHGReported

Janus Henderson Group plc

RecapView

May9

SATSReported

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$2.85

Revenue

Revenue figures provide insight into the company's sales performance and market demand.

$1.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+1.57%

Avg Stock Reaction

-0.34%

Last Quarter Recap

In Q3 2026, STERIS reported an EPS of $2.53, matching analyst expectations. The stock saw a modest increase of nearly 1% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect STERIS to report solid earnings, with a consensus EPS of $2.85. The market is closely watching how the company navigates ongoing challenges in the healthcare sector.

Bull Case

If STERIS exceeds EPS expectations, it could signal strong demand for its products and services, potentially boosting investor confidence.

Bear Case

Conversely, if the company misses EPS estimates, it may raise concerns about its growth prospects and market position.

Key Metrics to Watch

EPS

$2.85

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$1.6B

Revenue figures provide insight into the company's sales performance and market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will STERIS achieve an EPS of $2.85 or higher?

This figure is critical as it sets the tone for investor confidence and reflects the company's profitability.

What insights will management provide regarding revenue growth?

Understanding revenue trends can indicate how well STERIS is performing in the competitive healthcare market.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may be underestimating the impact of recent healthcare trends on STERIS's revenue growth potential.

Supporting Evidence

The company's strong historical EPS beat rate of 88% suggests it often exceeds expectations.

Options pricing indicates a significant expected move, which may reflect uncertainty not captured in consensus estimates.

Key Risk

If management provides strong guidance on revenue growth, it could challenge the current consensus outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it reflects STERIS's ability to navigate market challenges and meet investor expectations.

Bull Confirmed If

An EPS of $2.90 or above would confirm strong operational performance.

Bear Confirmed If

An EPS below $2.81 could indicate underlying issues affecting profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±5.6%

Historical Avg

±1.0%

Pricing rich

The options market is pricing in a significant move following the earnings report, suggesting heightened volatility expectations.

Options are pricing ±6.0% while STE has averaged ±1.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

24.0%

Calls (3K)P/C Ratio: 0.90Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 6 of 12 (50%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If STERIS beats expectations, history suggests the stock could see a modest increase, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may remain stable, but cautious commentary could lead to volatility.

Miss

A miss on EPS could lead to a decline, with history suggesting an average drop of around 1% following such outcomes.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

3 buys·0 sells

Members

House only

Est. Notional

$3,003.00–$45,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in infection prevention.
2Insights into market demand trends for healthcare equipment.
3Management's outlook on cost pressures and how they plan to address them.
4Details on any recent acquisitions or partnerships that could impact growth.
5Comments on competitive positioning within the healthcare equipment sector.